175 related articles for article (PubMed ID: 22336146)
21. Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching.
Widmer DS; Hoek KS; Cheng PF; Eichhoff OM; Biedermann T; Raaijmakers MIG; Hemmi S; Dummer R; Levesque MP
J Invest Dermatol; 2013 Oct; 133(10):2436-2443. PubMed ID: 23474946
[TBL] [Abstract][Full Text] [Related]
22. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.
Jönsson G; Busch C; Knappskog S; Geisler J; Miletic H; Ringnér M; Lillehaug JR; Borg A; Lønning PE
Clin Cancer Res; 2010 Jul; 16(13):3356-67. PubMed ID: 20460471
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.
Bertucci F; Pages C; Finetti P; Rochaix P; Lamant L; Devilard E; Nguyen C; Houlgatte R; Birnbaum D; Xerri L; Brousset P
Anticancer Res; 2007; 27(5A):3441-9. PubMed ID: 17970093
[TBL] [Abstract][Full Text] [Related]
25. Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion.
Kääriäinen E; Nummela P; Soikkeli J; Yin M; Lukk M; Jahkola T; Virolainen S; Ora A; Ukkonen E; Saksela O; Hölttä E
J Pathol; 2006 Oct; 210(2):181-91. PubMed ID: 16924594
[TBL] [Abstract][Full Text] [Related]
26. Cancer/testis genes expression in human melanoma cell lines.
Mikhaylova IN; Kovalevsky DA; Morozova LF; Golubeva VA; Cheremushkin EA; Lukashina MI; Voronina ES; Burova OS; Utyashev IA; Kiselev SL; Demidov LV; Beabealashvilli RSh; Baryshnikov AY
Melanoma Res; 2008 Oct; 18(5):303-13. PubMed ID: 18781128
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA regulation of melanoma progression.
Bonazzi VF; Stark MS; Hayward NK
Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
[TBL] [Abstract][Full Text] [Related]
28. Molecular markers in melanoma.
Kashani-Sabet M
Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
[TBL] [Abstract][Full Text] [Related]
29. A gene expression signature of invasive potential in metastatic melanoma cells.
Jeffs AR; Glover AC; Slobbe LJ; Wang L; He S; Hazlett JA; Awasthi A; Woolley AG; Marshall ES; Joseph WR; Print CG; Baguley BC; Eccles MR
PLoS One; 2009 Dec; 4(12):e8461. PubMed ID: 20041153
[TBL] [Abstract][Full Text] [Related]
30. The CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype Switching.
Lessard L; Liu M; Marzese DM; Wang H; Chong K; Kawas N; Donovan NC; Kiyohara E; Hsu S; Nelson N; Izraely S; Sagi-Assif O; Witz IP; Ma XJ; Luo Y; Hoon DSB
J Invest Dermatol; 2015 Oct; 135(10):2464-2474. PubMed ID: 26016895
[TBL] [Abstract][Full Text] [Related]
31. Melanoma molecular classes and prognosis in the postgenomic era.
Tremante E; Ginebri A; Lo Monaco E; Frascione P; Di Filippo F; Terrenato I; Benevolo M; Mottolese M; Pescarmona E; Visca P; Natali PG; Giacomini P
Lancet Oncol; 2012 May; 13(5):e205-11. PubMed ID: 22554548
[TBL] [Abstract][Full Text] [Related]
32. Molecular classification of cutaneous malignant melanoma by gene expression profiling.
Bittner M; Meltzer P; Chen Y; Jiang Y; Seftor E; Hendrix M; Radmacher M; Simon R; Yakhini Z; Ben-Dor A; Sampas N; Dougherty E; Wang E; Marincola F; Gooden C; Lueders J; Glatfelter A; Pollock P; Carpten J; Gillanders E; Leja D; Dietrich K; Beaudry C; Berens M; Alberts D; Sondak V
Nature; 2000 Aug; 406(6795):536-40. PubMed ID: 10952317
[TBL] [Abstract][Full Text] [Related]
33. Identification of differentially expressed genes in matched formalin-fixed paraffin-embedded primary and metastatic melanoma tumor pairs.
Jewell R; Mitra A; Conway C; Iremonger J; Walker C; de Kort F; Cook M; Boon A; Speirs V; Newton-Bishop J
Pigment Cell Melanoma Res; 2012 Mar; 25(2):284-6. PubMed ID: 22212396
[No Abstract] [Full Text] [Related]
34. Inhibition of p38/MK2 Signaling Prevents Vascular Invasion of Melanoma.
Wenzina J; Holzner S; Puujalka E; Cheng PF; Forsthuber A; Neumüller K; Schossleitner K; Lichtenberger BM; Levesque MP; Petzelbauer P
J Invest Dermatol; 2020 Apr; 140(4):878-890.e5. PubMed ID: 31622599
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and biological heterogeneity of melanomas].
Delyon J; Mourah S; Lebbé C
Rev Prat; 2014 Jan; 64(1):72-3. PubMed ID: 24649551
[No Abstract] [Full Text] [Related]
36. Estimation of Prognosis in Invasive Cutaneous Melanoma: An Independent Study of the Accuracy of a Gene Expression Profile Test.
Greenhaw BN; Zitelli JA; Brodland DG
Dermatol Surg; 2018 Dec; 44(12):1494-1500. PubMed ID: 29994951
[TBL] [Abstract][Full Text] [Related]
37. Pathology of melanoma.
Elder DE
Surg Oncol Clin N Am; 2015 Apr; 24(2):229-37. PubMed ID: 25769708
[TBL] [Abstract][Full Text] [Related]
38. Network models of primary melanoma microenvironments identify key melanoma regulators underlying prognosis.
Song WM; Agrawal P; Von Itter R; Fontanals-Cirera B; Wang M; Zhou X; Mahal LK; Hernando E; Zhang B
Nat Commun; 2021 Feb; 12(1):1214. PubMed ID: 33619278
[TBL] [Abstract][Full Text] [Related]
39. Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities.
Lauss M; Nsengimana J; Staaf J; Newton-Bishop J; Jönsson G
J Invest Dermatol; 2016 Dec; 136(12):2502-2505. PubMed ID: 27345472
[No Abstract] [Full Text] [Related]
40. Microenvironment-derived factors driving metastatic plasticity in melanoma.
Kim IS; Heilmann S; Kansler ER; Zhang Y; Zimmer M; Ratnakumar K; Bowman RL; Simon-Vermot T; Fennell M; Garippa R; Lu L; Lee W; Hollmann T; Xavier JB; White RM
Nat Commun; 2017 Feb; 8():14343. PubMed ID: 28181494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
